Do weight loss injections make you lose muscle?

Why you're asking this, and why the question is worth taking seriously

A lot of people start looking into weight loss injections and hit the same worry: what if I lose muscle as well as fat? It's a completely fair concern, and not a small one. Muscle isn't just about the gym, it supports your metabolism, your strength as you age, your blood sugar regulation and your day-to-day energy. Losing a significant proportion of it would be a real cost, even if the scales were moving in the right direction.

The honest answer is that some lean mass loss is nearly inevitable whenever you lose weight quickly. That's true of any calorie deficit, whether you're on medication or not. The more useful question is whether GLP-1 and dual-agonist medicines make this worse than the alternatives, and the evidence suggests they don't, and may actually compare favourably with more aggressive dietary restriction.

Understanding how weight loss injections interact with muscle loss in practice is worth doing before you start, because knowing the risk in advance is exactly when you can do something about it. If you'd like a broader overview of how these medicines work, the weight loss injection guide covers the fundamentals.

What the research actually shows about lean mass during GLP-1 treatment

Studies on both tirzepatide and semaglutide consistently show that weight lost during treatment includes a mix of fat mass and lean mass, the split varies, but lean mass typically accounts for roughly 20–30% of total weight lost. That ratio is broadly in line with what's seen during supervised dietary programmes, and in some analyses compares favourably with them.

One reason may be the way these medicines work. Rather than a sudden, steep calorie cut, appetite falls gradually as doses increase over several months, the prescriber titrates from a low starting point over weeks. A more measured deficit may give the body more time to adapt than a rapid crash diet does, although head-to-head evidence on this specific point is still developing. The relationship between these injections and muscle mass is an active area of clinical research.

SURMOUNT-1, the pivotal trial for tirzepatide published in the New England Journal of Medicine, reported an average body-weight reduction of around 20–21% at the highest dose over 72 weeks, involving 2,539 adults. Body composition data from that programme showed fat mass drove the majority of the change. The detail on how muscle mass is affected gives more context on what those composition numbers mean in practice.

The two things most likely to change your outcome

Protein and resistance exercise. These aren't caveats bolted on as an afterthought, they're the most consistently supported interventions for protecting lean mass during a calorie deficit, and NHS guidance on weight management actively recommends both alongside any treatment programme.

Protein keeps the building blocks of muscle available even when total calorie intake is reduced. Many people on tirzepatide or semaglutide find their appetite falls so sharply that hitting a reasonable protein target takes conscious effort. If your meals are smaller, the proportion of them that's protein matters more. A target of around 1.2–1.6g per kilogram of body weight per day is a commonly referenced range in dietetic practice, though your specific goal is best set with a dietitian or your prescriber.

Resistance exercise (anything that asks your muscles to work against load, from weights to resistance bands to body-weight moves) signals to the body that lean tissue is worth holding onto. Cardio matters for health, but it doesn't carry the same muscle-preservation signal. The overview of weight loss injections explains how lifestyle support fits alongside treatment more broadly. Some people find it useful to check whether the cost of supervised support makes sense for them; the context around injection costs is worth reading before making that call.

What to discuss with your prescriber before and during treatment

Muscle preservation isn't a side conversation, it's part of responsible prescribing for these medicines. Before treatment starts, a prescriber will look at your overall health picture: your activity levels, any conditions that might affect your ability to exercise, your diet history. If you're already fairly active, that's a meaningful protective factor worth flagging.

During treatment, if you notice you're struggling to eat enough protein, or that fatigue is making it hard to keep up with exercise, that's worth raising at your next clinical review rather than quietly managing alone. Aftercare conversations are there precisely for this. It's also worth knowing that hair thinning is occasionally reported during rapid weight loss, a separate but related concern you can read about on the page covering weight loss injections and hair.

These are prescription-only medicines, which means a clinician makes the call on whether they're right for you, and that includes weighing up any factors that might influence how you respond to treatment. Our clinical team reviews every consultation in person. If you're thinking about starting treatment and want to talk through the muscle question as part of that, checking your eligibility is the place to begin.